Medtrum today unveiled the 300-unit version of its TouchCare Nano tubeless automated insulin delivery patch pump.

The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest ...

Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...

Insulet has secured US Food and Drug Administration (FDA) clearance for an algorithm advancement within its Omnipod 5 ...

Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.

December 4, 2025 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the ...

PreciseDx, the leading innovator behind PreciseBreast, a novel AI digital pathology test, announces the upcoming presentation of three abstracts that further validate the test's ability to assess risk ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...

Torrey Pines High School. I’ve been living with Type 1 diabetes for over five years, and this weekend, I’ll be attending the ...

While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still cannot maintain steady control. Implantable insulin pumps offer another option ...